Stocks-VCYT-Veracyte Inc

VCYT Veracyte Inc

33.48 -0.39 (-1.15%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-VCYT-Veracyte Inc
VCYT Veracyte Inc
Trade

Overview

Prev Close 33.48
Day's Range 32.88 - 33.81
52 Week Range 18.49 - 35.43
Average Volume (3M) 933.43K
1-Year Return 53.06%
Beta2.1944
Market Cap 2.6B
P/E Ratio-45.5
Revenue399.58M
EPS-0.7444
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Medical Specialties
CEO
Marc A. Stapley
Employees
815

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Veracyte Inc's revenues increased by 21.76% and amounted to 361.05M. Net income decreased by 103.51% to -74.40M. Net assets decreased by 2.89% to 1.04B and EPS decreased from -0.51 to -1.02.
VCYT's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
63.87%
Net Profit Margin
-21.51%
Operating Margin
1.86%
Return On Investment
-6.07%
09/23
12/23
03/24
06/24
Total Revenue
90.11M
98.2M
96.84M
114.43M
Gross Profit
55.74M
68.82M
61.8M
77.03M
Operating Income
8.36M
-1.31M
2.46M
8.8M
Net Income
-29.62M
-28.29M
-1.86M
5.73M